source
- Pfizer’s strategy chief Andrew Baum steps down; Helus Pharma swaps out CEO after two months→ Ex-Citi analyst Andrew Baum has left his role as chief strategy and innovation officer at Pfizer, but he will be a senior strategic advisor to CEO Albert Bourla. BMO Capital Markets broke the new…Endpoints · 3mo ago↗ source
- Daiichi Sankyo postpones annual results, stock dipsDaiichi Sankyo has pushed back the reporting of its annual results, saying it needs more time to finalize the numbers. The Japanese company had intended to unveil its financials for its fiscal year…Endpoints · 3mo ago↗ source
- FDA approves Regeneron's hearing loss gene therapy OtarmeniRegeneron has won the first-ever FDA approval for a gene therapy to treat a rare type of inherited hearing loss, and the company plans to offer the treatment for free in the US, though that ...